Patterns of Perioperative Hormone Therapy for Gender-Affirming Surgery
Authors:
- 25 January 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 92 (4) , 442-446
Abstract
Introduction: There is no consensus regarding perioperative hormone replacement therapy (HRT) for gender-affirming surgery (GAS). Common concerns for continuing perioperative HRT included risk of deep vein thrombosis (DVT) or hematoma. However, discontinuing HRT is not risk free and may cause mood swing or increased anxiety. Our study aimed to investigate current patterns of HRT before GAS worldwide. Methods: The first stage of Delphi technique was implemented by sending a 27-item survey to all surgeons (total n = 150; 94 plastic surgeon, 35 urologist, and 21 gynecologists) of the World Professional Association for Transgender Health who perform GAS. Survey themes included the hormone type, duration, and usage of DVT prophylaxis. Results: Overall survey response rate was 34% (total n = 51; 8 urologists, 35 plastic surgeons, and 8 gynecologists). The majority of surgeons are US-based (n = 39, 76%). The most common HRTs are in injection form (n = 28, 55%). The majority of surgeons do not stop HRT before GAS and do provide DVT prophylaxis to all patients <1 week after GAS. The most common procedure that surgeons discontinue HRT is feminizing bottom surgery (43%). For surgeons who discontinue HRT before GAS, there is a wide variation on discontinuation schedule. Conclusions: There is considerable variation in perioperative HRT patterns for GAS. Further research is needed to develop a data-driven consensus guideline to provide high quality of care for transgender and nonbinary patients.Keywords
This publication has 15 references indexed in Scilit:
- Hematoma following gender-affirming mastectomy: A systematic review of the evidenceJournal of Plastic, Reconstructive & Aesthetic Surgery, 2022
- The Effect of Preoperative Gender-Affirming Hormone Therapy Use on Perioperative Adverse Events in Transmasculine Individuals Undergoing Masculinizing Chest Surgery for Gender AffirmationAesthetic Surgery Journal, 2022
- Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression StudyFrontiers in Endocrinology, 2021
- Complications and Patient-reported Outcomes in Transfemale Vaginoplasty: An Updated Systematic Review and Meta-analysisPlastic and Reconstructive Surgery - Global Open, 2021
- No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-Affirming SurgeryThe Journal of Clinical Endocrinology & Metabolism, 2021
- Association of Surgical Risk With Exogenous Hormone Use in Transgender PatientsJAMA Surgery, 2019
- Delphi methodology in health research: how to do it?European Journal of Integrative Medicine, 2015
- Endocrine treatment of transsexual persons: an Endocrine Society Clinical Practice Guideline: commentary from a European perspectiveEuropean Journal of Endocrinology, 2010
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2009
- Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomyClimacteric, 2009